<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Tue, 16 Sep 2025 10:48:06 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder</title><link>https://www.benzinga.com/news/fda/25/09/47688060/adial-pharmaceuticals-highlights-favorable-comments-from-fda</link><image_url>https://cdn.benzinga.com/files/images/story/2025/09/16/ADIL.png?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Adial Pharmaceuticals received FDA backing for its Phase 3 AD04 trial, including endpoints and strategies for targeted populations in Alcohol Use Diso...</description><pubDate>Tue, 16 Sep 2025 13:03:43 GMT</pubDate></item><item><title>Demystifying Chubb: Insights From 10 Analyst Reviews</title><link>https://www.benzinga.com/insights/analyst-ratings/25/09/47688008/demystifying-chubb-insights-from-10-analyst-reviews</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Latest Ratings for CB Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Raymond James Maintains Strong Buy Jan 2022 Mor...</description><pubDate>Tue, 16 Sep 2025 13:02:12 GMT</pubDate></item><item><title>Analyst Expectations For MetLife's Future</title><link>https://www.benzinga.com/insights/analyst-ratings/25/09/47687989/analyst-expectations-for-metlifes-future</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Latest Ratings for MET Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Jan 2022 Jefferies Initiates Coverage On Buy Jan 2022 Wol...</description><pubDate>Tue, 16 Sep 2025 13:01:55 GMT</pubDate></item><item><title>Where The Hartford Insurance Gr Stands With Analysts</title><link>https://www.benzinga.com/insights/analyst-ratings/25/09/47687974/where-the-hartford-insurance-gr-stands-with-analysts</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Latest Ratings for HIG Date Firm Action From To Jan 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Wells Fargo Maintains Overweight Nov 2021 Gold...</description><pubDate>Tue, 16 Sep 2025 13:01:20 GMT</pubDate></item><item><title>What Analysts Are Saying About VF Stock</title><link>https://www.benzinga.com/insights/analyst-ratings/25/09/47687953/what-analysts-are-saying-about-vf-stock</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>Latest Ratings for VFC Date Firm Action From To Jan 2022 Truist Securities Maintains Hold Jan 2022 Deutsche Bank Maintains Buy Jan 2022 Barclays Maint...</description><pubDate>Tue, 16 Sep 2025 13:01:05 GMT</pubDate></item></channel></rss>